Article snapshot taken from Wikipedia with creative commons attribution-sharealike license.
Give it a read and then ask your questions in the chat.
We can research this topic together.
This article may have been created or edited in return for undisclosed payments, a violation of Misplaced Pages's terms of use. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. (September 2017)
Cancer drug discovery and development, clinical trial data sharing, deletions by transposons, X-recessive disorders in females, molecular genetics of human cancers
Scientific career
Fields
Molecular Biology, Clinical Translation, Drug Discovery and Development, Clinical Data Sharing, Executive Management, Governance
Before joining SBP, Nisen was Senior Vice President of Science and Innovation at GlaxoSmithKline (GSK). In this role, he facilitated innovation and integration of R&D across GSK's global organization and contributed to the discovery, development and commercialization of many drugs. Earlier in his career at GSK, he held various key positions, including interim Chief Medical Officer, Senior Vice President and Oncology Therapy Area Head, Senior Vice President of Cancer Research, and Senior Vice President of Clinical Pharmacology and Discovery Medicine.
Formerly, he was the Lowe Foundation Professor of Neuro-Oncology at the University of Texas Southwestern Medical Center. He headed a basic research laboratory and was a practicing physician in pediatric hematology-oncology. He was a member of the Genetics and Development Graduate Training Program.
